Facebook Linkedin RSS Twitter Youtube
Home 2024

Healthcare financing

Seaport Eyes Platform, Pipeline Growth with $225M Series B
Drug Discovery

Seaport Eyes Platform, Pipeline Growth with $225M Series B

With $5.3M in Funding, clock.bio Makes Progress on Longevity Research Using Stem Cells
Drug Discovery

With $5.3M in Funding, clock.bio Makes Progress on Longevity Research Using Stem Cells

StockWatch: BioAge, Orum Reflect Renewed Interest in IPOs
Drug Discovery

StockWatch: BioAge, Orum Reflect Renewed Interest in IPOs

Pairwise Raises $40M in Series C, Inks Gene Editing Agreement with Corteva
Genome Editing

Pairwise Raises $40M in Series C, Inks Gene Editing Agreement with Corteva

$600M+ Credit Firm Targets Life-Sci Companies in Later Stages
Drug Discovery

$600M+ Credit Firm Targets Life-Sci Companies in Later Stages

Flagship Pioneering Raises $3.6B, Plans 25 New Startups
Drug Discovery

Flagship Pioneering Raises $3.6B, Plans 25 New Startups

Neoadjuvant Immunotherapy for Melanoma Shows Promise in Phase III Study
Cancer

Neoadjuvant Immunotherapy for Melanoma Shows Promise in Phase III Study

Drug-Pricing Strategies to Reduce Financial Burdens of Immunotherapy
News

Drug-Pricing Strategies to Reduce Financial Burdens of Immunotherapy

2025 Cell & Gene Therapy Reimbursement Outlook
Bioprocessing

2025 Cell & Gene Therapy Reimbursement Outlook

StockWatch: Analysts Weigh Obesity Drug Market Pegged at $100B by 2030
Drug Discovery

StockWatch: Analysts Weigh Obesity Drug Market Pegged at $100B by 2030

123...22Page 1 of 22
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.